TAKEDA PHARMACEUTICAL CO LTD NPV revenue breakdown overview

TAKEDA PHARMACEUTICAL CO LTD NPV revenue for the last year amounted to 26.11 B EUR, the most of which — 7.45 B EUR — came from its highest performing source at the moment, Gastroenterology, the year earlier bringing 7.60 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought TAKEDA PHARMACEUTICAL CO LTD NPV 13.44 B EUR, and the year before that — 14.61 B EUR.